A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Roswell Park Cancer Institute
Center for International Blood and Marrow Transplant Research
Ohio State University Comprehensive Cancer Center
Massachusetts General Hospital
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
M.D. Anderson Cancer Center
Children's Hospital of Philadelphia
Duke University
Thomas Jefferson University
Thomas Jefferson University
Baylor College of Medicine
UNC Lineberger Comprehensive Cancer Center
University of Rochester
Affiliated Hospital of Qinghai University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ossium Health, Inc.
New York Medical College
Roswell Park Cancer Institute
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Columbia University
European Institute of Oncology
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
University of Nebraska
M.D. Anderson Cancer Center
Scripps Health
Scripps Health
New York Medical College
University of Alabama at Birmingham
Bellicum Pharmaceuticals
Rutgers, The State University of New Jersey
Roswell Park Cancer Institute
West Virginia University
Memorial Sloan Kettering Cancer Center
Phoenix Children's Hospital
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University College, London
Roswell Park Cancer Institute
University of Arizona
Massachusetts General Hospital
University of Illinois at Chicago
New York Blood Center
M.D. Anderson Cancer Center
Federal University of Juiz de Fora